Mirchandani, D., Hochster, H., Hamilton, A., Liebes, L., Yee, H., Curtin, J. P., . . . Muggia, F. M. (2005). Phase I study of combined pegylated liposomal doxorubicin with protracted daily topotecan for ovarian cancer. Clinical cancer research, 11(16), 5912. https://doi.org/10.1158/1078-0432.CCR-04-1240
Citace podle Chicago (17th ed.)Mirchandani, Deepu, et al. "Phase I Study of Combined Pegylated Liposomal Doxorubicin with Protracted Daily Topotecan for Ovarian Cancer." Clinical Cancer Research 11, no. 16 (2005): 5912. https://doi.org/10.1158/1078-0432.CCR-04-1240.
Citace podle MLA (9th ed.)Mirchandani, Deepu, et al. "Phase I Study of Combined Pegylated Liposomal Doxorubicin with Protracted Daily Topotecan for Ovarian Cancer." Clinical Cancer Research, vol. 11, no. 16, 2005, p. 5912, https://doi.org/10.1158/1078-0432.CCR-04-1240.